🍀 Spring Appointment, Lucky Draw Gifts! Growth Value Issue 1️⃣7️⃣ Spring Lucky Draw Carnival Begins!
Seize Spring Luck! 👉 https://www.gate.com/activities/pointprize?now_period=17
🌟 How to Participate?
1️⃣ Enter [Plaza] personal homepage, click the points icon next to your avatar to enter [Community Center]
2️⃣ Complete plaza or hot chat tasks like posting, commenting, liking, and speaking to earn growth value
🎁 Every 300 points can draw once, 10g gold bars, Gate Red Bull gift boxes, VIP experience cards and more great prizes await you!
Details 👉 https://www.gate.com/announcements/article/
亨迪药业:盐酸埃克替尼获上市申请批准
亨迪药业公告,近日收到国家药品监督管理局核准签发的关于盐酸埃克替尼的《化学原料药上市申请批准通知书》(证书编号:2026YS00095)。盐酸埃克替尼是我国自主研发的EGFR酪氨酸激酶抑制剂类靶向药,主要用于治疗表皮生长因子受体(EGFR)基因存在敏感突变的局部晚期或转移性非小细胞肺癌,也可用于既往化疗失败的晚期非小细胞肺癌患者的治疗。